Fate Therapeutics, Inc. (NASDAQ:FATE), a clinical-stage biopharmaceutical company with a market capitalization of $156.6 million, is at a pivotal juncture in its development of programmed cellular ...

Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ...

The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...

Garuda Aerospace invests to develop Andhra Pradesh as India's first 'Drone City,' driving drone innovation and manufacturing.

Speaking at West 2025 in San Diego on Tuesday, Lt. Artem Sherbinin said those use cases will span three areas in which the ...

A 57,000 square foot building now stands as the first of many for future innovators in the USD Discovery District’s research ...

This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of opioids.

Learn about the different R&D projects Idaho National Laboratory will conduct with Boise State University and the University ...

As we settle into 2025, it’s clear that the future of software development is being shaped by trends that prioritize efficiency, intelligence and adaptability. And while adjusting to change isn’t ...

We recently compiled a list of the 12 Stocks That Will Double in 2025. In this article, we are going to take a look at where ...